Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Georg Griesinger

Showing results (91-100 of 119) with videos related to

Pageof 12
Sort By:
Fertility and Sterility|April 25, 2007
Triggering of final oocyte maturation with gonadotropin-releasing hormone agonist or human chorionic gonadotropin. Live birth after frozen-thawed embryo replacement cyclesGeorg Griesinger, E M Kolibianakis, E G Papanikolaou, et al.
Reproductive Biomedicine Online|January 1, 2019
Dydrogesterone: pharmacological profile and mechanism of action as luteal phase support in assisted reproductionGeorg Griesinger, Herman Tournaye, Nick Macklon, et al.
Fertility and Sterility|June 10, 2026
Reproductive Outcomes in Programmed Ovulatory versus Modified Natural Cycle FET: A Propensity Score-Matched Analysis of Prospective and Retrospective CohortsPhilippos Edimiris, Timur Tekesin, Noemi Hamala, et al.
Journal of Assisted Reproduction and Genetics|October 12, 2022
Improving analysis of the vaginal microbiota of women undergoing assisted reproduction using nanopore sequencingTheresa Lüth, Simon Graspeuntner, Kay Neumann, et al.
Human Reproduction Open|April 2, 2026
Vaginal microbial community state types fail to predict IVF outcomes, whereas <i>Ureaplasma parvum</i> and <i>Lactobacillus iners</i> are negative predictors of implantation, clinical pregnancy, and live birthSimon Graspeuntner, Mariia Lupatsii, Noemi Hamala, et al.
Human Reproduction (Oxford, England)|January 21, 2009
Improving the patient's experience of IVF/ICSI: a proposal for an ovarian stimulation protocol with GnRH antagonist co-treatmentPaul Devroey, Mohamed Aboulghar, Juan Garcia-Velasco, et al.
Reproductive Biomedicine Online|December 15, 2015
The updated Cochrane review 2014 on GnRH agonist trigger: an indispensable piece of information for the clinicianMohamed A F M Youssef, Fulco Van der Veen, Hesham G Al-Inany, et al.
Human Reproduction (Oxford, England)|October 11, 2018
Oral dydrogesterone versus intravaginal micronized progesterone gel for luteal phase support in IVF: a randomized clinical trialGeorg Griesinger, Christophe Blockeel, Gennady T Sukhikh, et al.
The Cochrane Database of Systematic Reviews|January 21, 2011
Gonadotropin-releasing hormone agonist versus HCG for oocyte triggering in antagonist assisted reproductive technology cyclesMohamed Afm Youssef, Fulco Van der Veen, Hesham G Al-Inany, et al.
Reproductive Biomedicine Online|March 14, 2017
Ovarian response to 150 µg corifollitropin alfa in a GnRH-antagonist multiple-dose protocol: a prospective cohort studyTamara Lerman, Marion Depenbusch, Askan Schultze-Mosgau, et al.
Pageof 12

Showing results (91-100 of 119) with videos related to

Sort By:
Pageof 12
Fertility and Sterility|April 25, 2007
Triggering of final oocyte maturation with gonadotropin-releasing hormone agonist or human chorionic gonadotropin. Live birth after frozen-thawed embryo replacement cyclesGeorg Griesinger, E M Kolibianakis, E G Papanikolaou, et al.
Reproductive Biomedicine Online|January 1, 2019
Dydrogesterone: pharmacological profile and mechanism of action as luteal phase support in assisted reproductionGeorg Griesinger, Herman Tournaye, Nick Macklon, et al.
Fertility and Sterility|June 10, 2026
Reproductive Outcomes in Programmed Ovulatory versus Modified Natural Cycle FET: A Propensity Score-Matched Analysis of Prospective and Retrospective CohortsPhilippos Edimiris, Timur Tekesin, Noemi Hamala, et al.
Journal of Assisted Reproduction and Genetics|October 12, 2022
Improving analysis of the vaginal microbiota of women undergoing assisted reproduction using nanopore sequencingTheresa Lüth, Simon Graspeuntner, Kay Neumann, et al.
Human Reproduction Open|April 2, 2026
Vaginal microbial community state types fail to predict IVF outcomes, whereas <i>Ureaplasma parvum</i> and <i>Lactobacillus iners</i> are negative predictors of implantation, clinical pregnancy, and live birthSimon Graspeuntner, Mariia Lupatsii, Noemi Hamala, et al.
Human Reproduction (Oxford, England)|January 21, 2009
Improving the patient's experience of IVF/ICSI: a proposal for an ovarian stimulation protocol with GnRH antagonist co-treatmentPaul Devroey, Mohamed Aboulghar, Juan Garcia-Velasco, et al.
Reproductive Biomedicine Online|December 15, 2015
The updated Cochrane review 2014 on GnRH agonist trigger: an indispensable piece of information for the clinicianMohamed A F M Youssef, Fulco Van der Veen, Hesham G Al-Inany, et al.
Human Reproduction (Oxford, England)|October 11, 2018
Oral dydrogesterone versus intravaginal micronized progesterone gel for luteal phase support in IVF: a randomized clinical trialGeorg Griesinger, Christophe Blockeel, Gennady T Sukhikh, et al.
The Cochrane Database of Systematic Reviews|January 21, 2011
Gonadotropin-releasing hormone agonist versus HCG for oocyte triggering in antagonist assisted reproductive technology cyclesMohamed Afm Youssef, Fulco Van der Veen, Hesham G Al-Inany, et al.
Reproductive Biomedicine Online|March 14, 2017
Ovarian response to 150 µg corifollitropin alfa in a GnRH-antagonist multiple-dose protocol: a prospective cohort studyTamara Lerman, Marion Depenbusch, Askan Schultze-Mosgau, et al.
Pageof 12